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Abstract
Background: Jacobsen syndrome is a rare contiguous gene disorder that results from a terminal
deletion of the long arm of chromosome 11. It is typically characterized by intellectual disability, a
variety of physical anomalies and a distinctive facial appearance. The 11q deletion has traditionally
been identified by routine chromosome analysis. Array-based comparative genomic hybridization
(array-CGH) has offered new opportunities to identify and refine chromosomal abnormalities in
regions known to be associated with clinical syndromes.
Results: Using the 1 Mb BAC array (Spectral Genomics), we screened 70 chromosomally normal
children with idiopathic intellectual disability (ID) and congenital abnormalities, and identified five
cases with submicroscopic abnormalities believed to contribute to their phenotypes. Here, we
provide detailed molecular cytogenetic descriptions and clinical presentation of two unrelated
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subjects with de novo submicroscopic deletions within chromosome bands 11q24-25. In subject 1
the chromosome rearrangement consisted of a 6.18 Mb deletion (from 128.25–134.43 Mb) and an
adjacent 5.04 Mb duplication (from 123.15–128.19 Mb), while in subject 2, a 4.74 Mb interstitial
deletion was found (from 124.29–129.03 Mb). Higher resolution array analysis (385 K Nimblegen)
was used to refine all breakpoints. Deletions of the 11q24-25 region are known to be associated
with Jacobsen syndrome (JBS: OMIM 147791). However, neither of the subjects had the typical
features of JBS (trigonocephaly, platelet disorder, heart abnormalities). Both subjects had ID,
dysmorphic features and additional phenotypic abnormalities: subject 1 had a kidney abnormality,
bilateral preauricular pits, pectus excavatum, mild to moderate conductive hearing loss and
behavioral concerns; subject 2 had macrocephaly, an abnormal MRI with delayed myelination, fifth
finger shortening and squaring of all fingertips, and sensorineural hearing loss.
Conclusion: Two individuals with ID who did not have the typical clinical features of Jacobsen
syndrome were found to have deletions within the JBS region at 11q24-25. Their rearrangements
facilitate the refinement of the JBS critical region and suggest that a) deletion of at least 3 of the 4
platelet function critical genes (ETS-1, FLI-1 and  NFRKB  and  JAM3) is necessary for
thrombocytopenia; b) one of the critical regions for heart abnormalities (conotruncal heart defects)
may lie within 129.03 – 130.6 Mb; c) deletions of KCNJ1 and ADAMTS15 may contribute to the renal
anomalies in Jacobsen Syndrome; d) the critical region for MRI abnormalities involves a region from
124.6 – 129.03 Mb. Our results reiterate the benefits of array-CGH for description of new
phenotype/genotype associations and refinement of previously established ones.
Background
Array-based comparative genomic hybridization (array-
CGH) technology has vastly improved the resolution of
cytogenetic analysis, resulting in the detection of patho-
genic genomic imbalances in 9–17% of individuals with
normal chromosomes and undefined causes of intellec-
tual disability (ID) [1,2]. It has led not only to the descrip-
tion of new microdeletion/microduplication syndromes
(for review see Slavotinek, 2008 [3]) but has also facili-
tated a more accurate genotype-phenotype correlation in
cases of well established syndromes [4,5].
Jacobsen syndrome (JBS: OMIM 147791) was one of the
first recognised contiguous gene syndromes, resulting
from a terminal deletion of the long arm of chromosome
11 [6]. The typical clinical findings include thrombocyto-
penia, developmental delay, congenital heart disease and
short stature [7]. Dysmorphic features include hyperte-
lorism, ptosis, down slanting palpebral fissures, broad
nasal bridge with short nose, thin upper lip and low set,
malformed ears. In most cases, the partial monosomy of
11q is the result of a simple terminal deletion of 11q, with
breakpoints usually occurring at or distal to 11q23.3. In
around 25% of cases the 11q23.3 breakpoint has been
localized to the FRA11B fragile site in 11q23.3 [7,8]. In a
number of these patients it was demonstrated that there
was a CCG triplet repeat expansion and expression of this
fragile site in one of the parents [9]. Several other JBS dele-
tion breakpoints in the 11q23.3-qter region were also
shown to localize to CCG repeat expansions [10]. Intersti-
tial deletions of 11q23.3-qter are rarely reported [11], as
are cases of Jacobsen syndrome where the partial 11q
monosomy was due to an unbalanced translocation (for
example, Zahn et al. [12]). Several studies have provided
a genotype-phenotype correlation in an attempt to iden-
tify critical regions for the most common physical abnor-
malities seen in Jacobsen syndrome [7,8].
We report here the clinical and molecular cytogenetic
findings in two subjects with submicroscopic rearrange-
ments involving the 11q24-25 JBS critical region, detected
while screening 70 children with idiopathic ID and phys-
ical anomalies, using a whole-genome 1 Mb BAC array.
The recurrent 11q24-25 rearrangements and associated
phenotypes which are seen in our two patients are com-
pared to those found in patients with Jacobsen syndrome.
Methods
Subject recruitment
Two subjects with 11q rearrangements were identified
amongst 70 children with idiopathic ID having i) normal
karyotypes by routine cytogenetic testing at 500–550
band level resolution, ii) negative Fragile X testing by
DNA analysis, iii) a phenotype score ≥ 3 on the checklist
presented by DeVries et al [13]and iv) both parents avail-
able for testing. Clinical geneticists across Canada
recruited subjects for genomic screening according to the
above criteria.
G-banded Chromosome Analysis
Metaphase chromosomes were prepared from peripheral
blood samples using standard methods. GTG banding
was performed according to standard procedures.Molecular Cytogenetics 2008, 1:23 http://www.molecularcytogenetics.org/content/1/1/23
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1 Mb BAC Array-CGH
Array-CGH was performed as previously described using
the Spectral Genomics 1 Mb array [14]. The images were
analyzed using SPECTRALWARE BAC Array Analysis Soft-
ware v.2.0 (Spectral Genomics, Houston, TX). The posi-
tions of BAC clones were established using the database of
genomic variants http://projects.tcag.ca/variation/,
human genome build 35.
FISH
Fluorescence in situ hybridization (FISH) was performed
with BAC DNA clones (Spectral Genomics, Houston, TX)
or commercially available pre-labeled BAC clones (The
Centre for Applied Genomics, Toronto) to confirm any
deletions or duplications found by 1 Mb array-CGH
[14,15]. Slides were viewed on a Zeiss Axioplan 2 fluores-
cence microscope, and images captured using MacProbe
software (Applied Imaging, Santa Clara, CA). For each
probe, at least 10 metaphase cells were analyzed. Inter-
phase nuclei (50–100) were screened blindly in the case
of microduplications.
High Resolution Array-CGH
High resolution whole genome analysis was performed to
refine the boundaries of rearrangements found by 1 Mb
array-CGH, and also offered a second independent means
of confirming the result. High-resolution Nimblegen 385
K array-CGH was performed courtesy of Nimblegen.
Results
Subject 1 (Figure 1a)
Clinical description
Subject 1 is the product of a second pregnancy to a non-
consanguineous 32 year old mother and 34 year old
father, both of northern European descent. She was born
at 39 weeks gestation with a birth weight of 6 lb 11 oz. She
was noted at birth to have a single umbilical artery, bilat-
eral preauricular pits, bilateral simian creases, and ultra-
sound in early infancy showed an absent right kidney.
Physical examination at 1 month of age showed an active
alert female without dysmorphic facies; Occipital-frontal
head circumference (OFC), length and weight were 50th,
75th and 25–50th percentiles, respectively. Neurological
exam was normal. However, later assessment showed her
developmental milestones were delayed: she walked at
nearly 2 years, and began putting two words together at 2
1/2 years. Audiology testing demonstrated mild to moder-
ate conductive hearing loss in the left ear, and a less severe
right-sided loss. At 38 months, she was mildly unusual in
appearance with a broad nasal root, widely set eyes, and
preauricular pits. OFC was reduced to the 5th percentile,
relative to maintenance of height and weight approximat-
ing the 50th percentiles. Her voice was noted to be mono-
tone and nasal in quality. At age 6 1/2 years, concerns
were noted regarding social skills, with difficulty making
friends, an inability to concentrate and impulsiveness. She
was noted to have difficulty with gross motor skills. Her
systemic health was otherwise uncomplicated. At this
time, OFC, height and weight were 25th, 25th and 5th per-
centiles, respectively. She had an unusual facies with a
prominent forehead, receding hairline, and fine hair
which grew slowly. She had a high nasal root, squarish
nose, long philtrum, straight mouth and narrow upper
vermilion border. She had a pectus excavatum, and was
mildy hyperextensible. She was noted to be remarkably
like her mother in her facial appearance. When examined
at 9 years 1 month she had shown reasonable interval
growth, lean habitus, mild pectus excavatum, and star-
Facial features and physical abnormalities in subject 1 (a) and 2(b) Figure 1
Facial features and physical abnormalities in subject 1 (a) and 2(b).
a
b
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tling blue eyes. She continued to have behavioral con-
cerns including impulsive behaviour and difficulty with
strangers. Psychoeducational testing, including the WAIS
III (Weschler Adult Intelligence Scales – Version III), at age
16 indicated a borderline verbal score, a performance
score in the mild disability range and a full score within
the mild ID range. When seen at age 17 years 10 months
she was noted to have long facies, remarkable blue eyes,
an overhanging nose with a bulbous tip, well marked
philtrum, and protuberant lower lip. She had mildly short
D4 and D5 metacarpals. OFC, height and weight were at
the 2nd, 10th and < 5th percentiles, respectively. She had
rapid speech that was difficult to understand. A renal
ultrasound done at age 18 documented a left kidney of
normal size and location, and a smaller ectopic right kid-
ney. Other investigations included an ophthalmology
exam, which noted intermittent exotropia with mild myo-
pia. Karyotype, FISH for 22q11.2/13 microdeletions, Frag-
ile X studies, urinary organic acids and serum amino acids
were all normal.
Array CGH
A 5.04 Mb duplication (from 123.15–128.19 Mb) and
adjacent 6.18 Mb deletion (from 128.25–134.43 Mb) at
11q24.2-25 were detected (Figure 2). FISH using BAC
clones RP11-164A10 (dup), RP11-50B3 (dup), RP11-
206H9 (del) and RP11-469N6 (del) mapping within the
duplication and deletion regions confirmed the imbal-
ances in the patient, and showed them to be de novo (Fig-
ure 2). The duplication probes showed a discordant (1:2)
signal pattern in ~90% of interphase nuclei in subject 1
and < 20% nuclei in the parents, while the deletion probes
showed a single signal in 100% of subject 1's interphase
and metaphase cells (compared to < 20% nuclei in par-
ents). The number of analyzed cells was 20–100.
Subject 2 (Figure 1b)
Clinical description
This male child was initially seen in the Genetics Clinic at
8 months of age with developmental delay: specifically,
the inability to sit unsupported or pull himself into sitting
position, and macrocephaly (OFC > 98th percentile). He
was delivered at term following an uneventful pregnancy
and his weight and OFC at that time were both at the 25th
percentile. At an early age he was noted to have a combi-
nation of motor and language delays as well as difficulties
with socialization. MRI scans of the brain have shown evi-
dence of abnormal white matter lesions, which were
thought to be due to delayed myelination rather than a
progressive leukodystrophy. At age 7 years the patient was
re-assessed due to ongoing concerns regarding his devel-
opment, as well his physical appearance. His medical his-
tory was unremarkable except for mild sensorineural
hearing loss. He attended a regular classroom and was
able to complete grade level work but required a full-time
aide to help with some specific learning problems in read-
ing as well as behavioral issues. His social interaction had
improved significantly. His height, weight and OFC were
10–25th, 50th and 98th percentiles, respectively. He had rel-
ative macrocephaly with a prominent forehead (Figure
1b), a round face with a broad nose and slightly broad
nasal tip with a well-grooved philtrum. His right ear was
noted to be slightly smaller than the left and he had over-
folding of the helices. His hands showed some 5th finger
shortening and squaring of the fingertips (Figure 1b). His
physical appearance was not consistent with a diagnosa-
ble syndrome and a routine karytype as well as subtelom-
eric FISH analysis and Fragile X testing were normal. In
reviewing the family history, his brother also has ID but
with an otherwise very different, abnormal phenotype
and an array detected de novo duplication of 19p13.3 (~3
Mb). There was no evidence of 11q24-25 abnormality in
this brother. His parents and two older brothers are all
healthy without any cognitive or learning disabilities and
there were no reported paternity concerns.
Array CGH
A 4.74 Mb interstitial deletion was found at 11q24.2-24.3
(from 124.29–129.03 Mb) (Figure 2). FISH using BAC
clones RP11-50B3 and RP11-206H9 confirmed the dele-
tion and showed it to be de novo (Figure 2), as all 10 met-
aphases in subject 2 showed a hybridization signal on
only one chromosome 11 homologue (compared to 10
parental metaphases which all showed signals on both
chromosome 11 homologues).
Discussion
We report the constellation of clinical and molecular
cytogenetic features of two individuals with ID who have
de novo submicroscopic rearrangements of chromosome
11q24-25. These two individuals are of particular interest
since their deletions lie within the region that is com-
monly deleted in patients with Jacobsen syndrome [16].
Other than ID, neither of our patients exhibits the most
characteristic features of Jacobsen syndrome, which typi-
cally include thrombocytopenia or pancytopenia, cranio-
facial abnormalities (trigonocephaly) and cardiac defects
[6]). As a result, it is possible to re-examine and refine the
chromosomal regions responsible for the different pheno-
types found in both our patients, and those with JBS.
Paris-Trousseau syndrome (PTS)
This is the most common clinical finding (94%) in JBS
patients, and is characterized by thrombocytopenia and
platelet dysfunction. The critical region has been nar-
rowed down to the 6.8 Mb terminal portion of 11q (distal
to D11S1351, i.e. from 127.6 to 134.4 Mb) [7], and con-
tains three genes associated with hematopoiesis (ETS-1,
FLI-1 and NFRKB), and the JAM3 gene which is expressed
in platelets [17] (Figure 3). Deletion of FLI-1, in particu-Molecular Cytogenetics 2008, 1:23 http://www.molecularcytogenetics.org/content/1/1/23
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11q24-25 rearrangements found in subjects 1 and 2 Figure 2
11q24-25 rearrangements found in subjects 1 and 2. (a) Nimblegen array (385 K) profiles of chromosome 11 showed a 
5.04 Mb duplication and a 6.18 Mb deletion detected in subject 1. FISH confirmation of the duplication of clone RP11-50B3 (b) 
and deletion of clone RP11-206H19 (AP003775.3) (c) in subject 1. (d) Nimblegen array (385 K) profiles of chromosome 11 
showed a 4.74 Mb deletion of chromosome 11q24.2-24.3 in subject 2. FISH confirmation of the deletion of clones RP11-50B3 
and RP11-206H19 (AP003775.3) in subject 2 is shown in (e) and (f), respectively. Arrow indicates duplicated chromosome and 
arrowhead the deleted chromosomes.
e f
Deletion
d
0                 20               40                 60         80               100              120  Position (Mb)
Deletion
Duplication
a
0                 20               40                 60         80               100              120   Position (Mb)
c bMolecular Cytogenetics 2008, 1:23 http://www.molecularcytogenetics.org/content/1/1/23
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11q24.1-25 region, showing the previously defined [7] critical regions for some of the common Jacobsen syndrome features,  and the location of the rearrangements detected in the present subjects 1 and 2 Figure 3
11q24.1-25 region, showing the previously defined [7] critical regions for some of the common Jacobsen syn-
drome features, and the location of the rearrangements detected in the present subjects 1 and 2. Chromosome 
bands are shown on the left, and the megabase (Mb) position on the right, with the positions and functions of some genes of 
interest. The patients' deletions are represented by red vertical lines, and the duplication of subject 1 by a blue vertical line. 
The 780 Kb region of deletion overlap between these two patients is shown by a red shaded box, and includes the CpG island 
4929 (black arrow) that contains a (CCG)6 repeat. A third red vertical line labeled 'W' shows the size of the interstitial deletion 
reported by Wenger et al [11]. The critical regions [7] for MRI abnormalities (MRI), heart defects (H) and Paris-Trousseau syn-
drome (PTS) are shown by three vertical grey lines, with the proximal molecular marker indicated at the top of each line. A 
1.57 Mb refined critical region for conotruncal heart defects is represented by two arrowheads (from the distal end of subject 
2's deletion to the distal end of the deletion seen in the patient reported by Wenger et al [11].
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lar, is thought to be at least partly responsible for the
platelet/megakaryocyte defects observed in PTS patients
[18]. The absence of PTS in subject 2, in association with
the deletion of the ETS-1 and FLI-1 genes but the presence
of the NFRKB and JAM3 genes, would suggest that the lat-
ter two genes, or other as yet unidentified genes, may be
sufficient for normal platelet development and function
(Figure 3). PTS also was absent in subject 1, whose termi-
nal deletion includes NFRKB  and  JAM3  and who has
duplication of ETS-1 and FLI-1. Therefore, it is likely that
the platelet dysfunction and/or thrombocytopenia com-
monly observed in JBS might result from the combined
effect of deletion of least three of these genes, and that
deletion of only two of these genes is insufficient to cause
the PTS phenotype. This is consistent with the finding of
thrombocytopenia in a patient with an interstitial dele-
tion of 11q24, which included ETS-1, FLJ-1, NFRKB, but
excluded JAM3 (Wenger et al, [11]). In addition, as sug-
gested by Penny et al [8], the genetic background of the
individual might influence the expression PTS, since
around 6% of patients with 11q terminal deletions do not
have thrombocytopenia.
Craniofacial abnormalities
Based on deletion mapping in JBS patients [8], a region
influencing craniofacial development was speculated to
map distal to D11S1351 (127.6 Mb), with BARX2
(128.75 Mb) as a potential candidate gene, since it is
expressed in the neural and craniofacial structures during
development [19]. BARX2 is further implicated here by its
location within the small (780 Kb) area of deletion over-
lap for our two patients (Figure 3), both of whom display
some of the facial dysmorphism (broad nasal root and a
prominent forehead) that is seen in a significant propor-
tion of JBS patients.
Cardiac abnormalities
A variety of serious cardiac abnormalities is observed in
individuals with JBS, and genes which influence cardiac
development are believed to lie distal to D11S707 (125.8
Mb) [7] (Figure 3). Together, the deletions of subjects 1
and 2 span this entire critical region, yet neither individ-
ual has any heart anomaly. While the concurrent duplica-
tion in subject 1 may be able to somehow "compensate"
for the loss of any heart-function related genes, the iso-
lated interstitial deletion in subject 2 may be helpful to
refine this critical region. When taken together with the
subject reported by Wenger et al [11], a patient with
conotruncal heart defects and a larger interstitial 11q24
deletion, one can see that one area critical to cardiac
anomalies may reside in a 1.57 Mb region between
129.03 – 130.6 (i.e. from the distal end of subject 2's dele-
tion to the distal end of Wenger's deletion, Figure 3). This
small region contains several genes of interest; for exam-
ple, polymorphisms in SNX19 have been reported to be
associated with coronary disease [20], while ADAMTS8 is
involved in regulating angiogenesis [21]. As suggested by
Wenger et al [11], a second JBS cardiac critical region
responsible for flow defects may be located distal to 130.6
Mb. This region contains JAM3, previously identified as a
candidate gene for the JBS cardiac phenotype [22]. It is
evident that the 11q JBS region is likely to contain a
number of genes involved in cardiac function, which
would account for the variety, as well as the presence/
absence of heart defects observed in these patients.
Indeed, genes outside the refined critical region (129.04
Mb to 11qter), such as ROBO4 (maintains vascular integ-
rity) and KCNJ5 (highly expressed in heart) may also con-
tribute to the cardiac defects that are observed in some JBS
patients with larger deletions of 11q.
Kidney abnormalities
Grossfeld et al [7] found structural defects of the kidney to
occur in 8% of JBS patients. Two genes in 11q24.3, KCNJ1
and ADAMTS15, both of which are expressed in kidney,
are potentially responsible for the renal anomalies found
in subject 1. The KCNJ1 gene (at 128.2 Mb) lies within her
duplication/deletion breakpoint, which might have dis-
rupted the function of this gene, while ADAMTS15 lies
within her terminal deletion region (Figure 3). In addi-
tion, the contribution of her 11q24.1-3 duplication, a
region which includes NEPH2 (a gene which is known to
be expressed in kidney podocytes and whose protein
interacts with podocin), is unclear.
MRI abnormalities
51% of JBS patients have abnormal brain imaging, with
the critical region lying distal to 124.6 Mb (D11S2090)
[7] (Figure 3). A region common to both this critical
region and the deletion of subject 2, who has abnormal
white matter lesions on MRI, is from 124.6 – 129.03 Mb.
Potential candidate genes include FEZ1, predominantly
expressed in the brain and involved in axonal outgrowth
[23], and RICS, expressed during neural development and
which may regulate dendritic spine morphology and
strength [24].
In summary, although the large number of 11q24-25
genes that are imbalanced in subjects 1 and 2 (> 100)
makes identification of genes responsible for specific phe-
notypic features challenging, the small 11q24-25 rear-
rangement sizes within the larger 11q JBS critical region
are important contributors to understanding specific phe-
notype-genotype correlations. The high number of candi-
date genes located within the large, cytogenetically visible
JBS deletions makes it likely that many of the typical fea-
tures seen in JBS are due not just to monosomy of single
genes, but to the cumulative effect of a combination ofMolecular Cytogenetics 2008, 1:23 http://www.molecularcytogenetics.org/content/1/1/23
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contiguous genes, or possible gene-gene interaction. This
seems the most likely scenario, particularly when one con-
siders the discrepancies that exist between phenotypes of
some individuals, their deletion sizes, and the critical
regions that are defined by the majority of patients with a
particular phenotype. One should also keep in mind that
the critical regions defined by Grossfeld et al [7] and
Penny et al [8] were based on conventional karyotypes
and a selection of DNA markers from the 11q terminal
region. The use of whole genome array-CGH should facil-
itate a more accurate assessment of the types and sizes of
chromosomal rearrangements in JBS.
The occurrence of a terminal deletion of 11q24.3 to
11qter, and duplication of 11q24.2-24.3 in subject 1 is a
rare instance of a more complex rearrangement of 11q24-
25 region. The duplicated region almost certainly will
contribute to the patient's phenotype together with the
concurrent deletion. Similarly, the effect of the deletion
on the phenotypic expression of the 11q24.1-24.3 dupli-
cation should be taken into consideration when subject 1
is compared to other patients with duplications involving
11q24. In a review of 11q duplications, Delobel et al [25],
showed that patients with interstitial duplications involv-
ing 11q23.3-24 do not have heart abnormalities, but com-
monly exhibit microcephaly, growth retardation, scoliosis
and strabismus, which, except for the growth retardation,
were not seen in our subject 1. The simultaneous occur-
rence of deletion and duplication in the 11q24-25 region
in subject 1 may suggest the presence of low copy repeats
(LCRs) which could lead to non-allelic homologous
recombination, comparable to the 1 pter deletion/dupli-
cation event which can lead to 1 pter deletion syndrome
[26]. The identity of such LCRs, however, remains
unknown, since a comparison of segmental duplications
within the 5 Mb region proximal to the duplication did
not reveal significant homology. It is intriguing to con-
sider the possibility that subject 1's terminal deletion/
duplication could also be a result of a terminal deletion,
followed by at least one breakage-fusion-bridge cycle, as
was described for two cases with a terminal deletion/
inverted duplication of 1 pter [27]. Detailed sequence
analysis of the breakpoints in subject 1 would be required
for the understanding of the molecular mechanisms lead-
ing to this rearrangement.
It would be interesting to perform whole genome screen-
ing of individuals with both typical and atypical Jacobsen
syndrome, to test for the presence of complex rearrange-
ments of the 11qter region and to rule out any additional
rearrangements elsewhere in the genome. The results of
such efforts would enhance our knowledge of the syn-
drome by allowing more accurate phenotype/genotype
correlation.
Conclusion
Our molecular cytogenetic and clinical findings in two
subjects with submicroscopic 11q24-25 rearrangements
facilitate the refinement of the JBS critical region and sug-
gest that a) deletion of at least 3 of the 4 platelet function
critical genes (ETS-1, FLI-1 and NFRKB and JAM3) is nec-
essary for thrombocytopenia; b) one of the critical regions
for heart abnormalities (conotruncal heart defects) may
be within 129.03 – 130.6 Mb; c) deletions of KCNJ1 and
ADAMTS15  may contribute to the renal anomalies in
Jacobsen Syndrome d) the critical region for MRI abnor-
malities involves a region from 124.6 – 129.03 Mb. Our
results reiterate the benefits of array-CGH for description
of new phenotype/genotype associations and refinement
of previously established ones.
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